EpirubicinAntineoplastic Combined Chemotherapy ProtocolsAntibiotics, AntineoplasticCyclophosphamideDrug Administration ScheduleFluorouracilBreast NeoplasmsTreatment OutcomePaclitaxelTaxoidsChemotherapy, AdjuvantCisplatinRazoxaneDoxorubicinInfusions, IntravenousDeoxycytidineDisease-Free SurvivalVinblastineGranulocyte Colony-Stimulating FactorSurvival AnalysisNeoadjuvant TherapyAnthracyclinesMethotrexateDose-Response Relationship, DrugSurvival RateNeutropeniaDrug Therapy, CombinationIfosfamideAntineoplastic AgentsAlopeciaCombined Modality TherapyTime FactorsHematologic DiseasesEtoposideAdministration, OralNeoplasm StagingVincristineNauseaNeoplasm MetastasisLeukopeniaVomitingInjections, IntravenousProlyl HydroxylasesCarboplatinStomach NeoplasmsProspective StudiesFollow-Up StudiesAdenocarcinomaArea Under CurveDrug EvaluationRemission InductionStomatitisAntineoplastic Agents, PhytogenicLeucovorinMaximum Tolerated DoseNaphthacenesReceptor, erbB-2Drug Resistance, NeoplasmPrednisoneDrug InteractionsMastectomy, RadicalBiliary Tract NeoplasmsHeart Diseases